Population
Preclinical models: stripped frog sciatic nerve, anaesthetized guinea-pigs with ouabain-induced ventricular…
Comparison
Kö 1173 (1--2-amino-propane), administered… vs Lignocaine; untreated controls.
Design
Preclinical
Authors
Loading...
May support antidysrhythmic development in models; leaves open translation to human arrhythmias.
Kö 1173 is a novel antidysrhythmic agent that effectively reverses ouabain-induced ventricular fibrillation and depresses the maximum rate of depolarization in preclinical models.
Singh et al. (1972) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: